BUY EQUIMUCIL INJ 100ml ONLINE

We are delighted to introduce EQUIMUCIL INJ, a specialized injectable equine medication designed to support respiratory health and aid in the management of respiratory conditions in horses. EQUIMUCIL INJ offers a targeted solution for promoting respiratory comfort and optimizing lung function.

Key Features and Benefits:

1. Respiratory Health Support: EQUIMUCIL INJ is specifically formulated to support respiratory health in horses. It contains mucolytic agents that help thin and liquefy mucus, making it easier for horses to clear their airways. This promotes optimal lung function and helps maintain respiratory comfort.
2. Mucus Clearance: EQUIMUCIL INJ aids in the clearance of excess mucus from the respiratory tract. By reducing the viscosity of mucus, it supports the natural mechanisms of mucus clearance, helping horses expel mucus more effectively. This can be particularly beneficial for horses with respiratory conditions characterized by excessive mucus production.
3. Eases Breathing: By promoting mucus clearance and optimizing lung function, EQUIMUCIL INJ helps ease breathing in horses. It supports open and clear airways, allowing for improved airflow and more comfortable respiration. This can be especially important during periods of increased respiratory stress, such as exercise or exposure to environmental irritants.
4. Anti-Inflammatory Action: EQUIMUCIL INJ contains anti-inflammatory agents that help reduce inflammation in the respiratory tract. This can be beneficial for horses with respiratory conditions characterized by inflammation, such as bronchitis or allergic airway disease. By reducing inflammation, EQUIMUCIL INJ helps alleviate respiratory discomfort and promotes overall respiratory health.
5. Convenient Injectable Form: EQUIMUCIL INJ comes in a convenient injectable form, allowing for direct administration into the horse’s system. This ensures prompt absorption and onset of action. The 100ml size provides an ample supply for multiple administrations, as directed by your veterinarian.

Usage Instructions:

EQUIMUCIL INJ should only be administered under the guidance and supervision of a licensed veterinarian. The dosage and treatment duration will depend on your horse’s specific condition, severity of symptoms, and individual response. Follow the veterinarian’s instructions carefully for optimal results and to minimize any potential side effects.

Note:

EQUIMUCIL INJ is intended for use in horses and should not be used in animals intended for human consumption. Please consult with your veterinarian to determine the appropriate usage, dosage, and treatment plan for your horse.

Order EQUIMUCIL INJ from EquiCurePharm Today!

If you are seeking an effective injectable medication to support respiratory health and aid in the management of respiratory conditions in your horse, choose EQUIMUCIL INJ from EquiCurePharm. We are dedicated to providing high-quality equine products with discreet worldwide shipping. Place your order today and provide your horse with the respiratory support they need to maintain optimal comfort and well-being.

EQUIMUCIL INJ 100ml

تكوين:
N-acetylcysteine 0،2 جم / مل

دواعي الإستعمال:
أمراض الجهاز التنفسي للخيول (الحادة والمزمنة والمتفاقمة) وعلى وجه الخصوص مرض الانسداد الرئوي المزمن (COPD).

الجرعة وطريقة الاستعمال:
حقنة وريد .. الحقن في الوريد.
الجرعة الموصى بها هي 5-10 ملجم من الأسيتيل سيستئين / كجم من وزن الجسم / يوم لمدة 5-15 يومًا اعتمادًا على التطور السريري للمرض.
50 كجم من وزن الجسم: 1.2-2.5 مل من Equimucil المقابل لـ 250-500 مجم من الأسيتيل سيستئين ؛
100 كجم من وزن الجسم: 2.5-5.0 مل مقابل 500-1000 ملجم من الأسيتيل سيستئين ؛
200 كجم من الوزن: 5.0 إلى 10.0 مل مقابل 1.0-2.0 جم من الأسيتيل سيستئين ؛
400 كجم من الوزن: 10.0 إلى 20.0 مل مقابل 2.0-4.0 جم من الأسيتيل سيستئين ؛
500 كجم من الوزن: من 12.5 إلى 25.0 مل مقابل 2.5-5.0 جم من الأسيتيل سيستئين

INYECCIÓN EQUIMUCIL 100ml

Composición:
N-acetilcisteína 0,2 g / ml

Indicaciones:
Enfermedades del sistema respiratorio equino (agudas, crónicas y exacerbaciones) y en particular la enfermedad pulmonar obstructiva crónica (EPOC).

Dosificación y administración:
Inyección intravenosa.
La dosis recomendada es de 5-10 mg de acetilcisteína / kg pc / día durante 5-15 días dependiendo de la evolución clínica de la enfermedad.
50 kg de peso corporal: 1,2-2,5 ml de Equimucil correspondientes a 250-500 mg de acetilcisteína;
100 kg de peso corporal: 2,5-5,0 ml correspondientes a 500-1000 mg de acetilcisteína;
200 kg de peso: 5,0 a 10,0 ml correspondientes a 1,0-2,0 g de acetilcisteína;
400 kg de peso: 10,0 a 20,0 ml correspondientes a 2,0-4,0 g de acetilcisteína;
500 kg de peso: 12,5 a 25,0 ml correspondientes a 2,5-5,0 g de acetilcisteína